The Extent of Honeycombing on Computed Tomography Cannot Predict the Treatment Outcome of Patients with Acute Exacerbations of Interstitial Lung Disease

<div>Comparison of patients with high, middle, and low honeycomb scores. In patients with AEs of idiopathic ILDs and secondary ILDs and overall patients, there is no significant difference in 3-month mortality among the groups with low (0 point), middle (1–4 points), and high (≥5 points) honeycomb scores. AE, acute exacerbation; ILD, interstitial lung disease. (a) Overall. (b) Idiopathic. (c) Secondary.</div>

Canadian Respiratory Journal

fig3

Figure 3

Figure 3: The Extent of Honeycombing on Computed Tomography Cannot Predict the Treatment Outcome of Patients with Acute Exacerbations of Interstitial Lung Disease 

Figure 3 | The Extent of Honeycombing on Computed Tomography Cannot Predict the Treatment Outcome of Patients with Acute Exacerbations of Interstitial Lung Disease 